210 related articles for article (PubMed ID: 12088876)
1. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.
Yuan L; Collins AR; Dai J; Dubocovich ML; Hill SM
Mol Cell Endocrinol; 2002 Jun; 192(1-2):147-56. PubMed ID: 12088876
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice.
Collins A; Yuan L; Kiefer TL; Cheng Q; Lai L; Hill SM
Cancer Lett; 2003 Jan; 189(1):49-57. PubMed ID: 12445677
[TBL] [Abstract][Full Text] [Related]
3. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
[TBL] [Abstract][Full Text] [Related]
6. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the mt1 melatonin receptor in human breast cancer.
Ram PT; Dai J; Yuan L; Dong C; Kiefer TL; Lai L; Hill SM
Cancer Lett; 2002 May; 179(2):141-50. PubMed ID: 11888668
[TBL] [Abstract][Full Text] [Related]
8. Cyr61 promotes breast tumorigenesis and cancer progression.
Tsai MS; Bogart DF; Castañeda JM; Li P; Lupu R
Oncogene; 2002 Nov; 21(53):8178-85. PubMed ID: 12444554
[TBL] [Abstract][Full Text] [Related]
9. Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin.
Ram PT; Yuan L; Dai J; Kiefer T; Klotz DM; Spriggs LL; Hill SM
J Pineal Res; 2000 May; 28(4):210-8. PubMed ID: 10831156
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of estrogen receptor alpha function by antisense oligodeoxyribonucleotides.
Taylor AH; Pringle JH; Bell SC; Al-Azzawi F
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):219-31. PubMed ID: 11572599
[TBL] [Abstract][Full Text] [Related]
11. Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma.
Welter C; Theisinger B; Seitz G; Tomasetto C; Rio MC; Chambon P; Blin N
Lab Invest; 1992 Feb; 66(2):187-92. PubMed ID: 1735955
[TBL] [Abstract][Full Text] [Related]
12. Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.
González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Mateos S; Hill SM; Sánchez-Barceló EJ; Cos S
Oncol Rep; 2007 Apr; 17(4):947-53. PubMed ID: 17342341
[TBL] [Abstract][Full Text] [Related]
13. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
[TBL] [Abstract][Full Text] [Related]
15. Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium.
Poulsom R; Hanby AM; Lalani EN; Hauser F; Hoffmann W; Stamp GW
J Pathol; 1997 Sep; 183(1):30-8. PubMed ID: 9370944
[TBL] [Abstract][Full Text] [Related]
16. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.
Girgert R; Bartsch C; Hill SM; Kreienberg R; Hanf V
Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572
[TBL] [Abstract][Full Text] [Related]
17. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors.
Ram PT; Kiefer T; Silverman M; Song Y; Brown GM; Hill SM
Mol Cell Endocrinol; 1998 Jun; 141(1-2):53-64. PubMed ID: 9723886
[TBL] [Abstract][Full Text] [Related]
19. Coxsackie and adenovirus receptor is a target and a mediator of estrogen action in breast cancer.
Vindrieux D; Le Corre L; Hsieh JT; Métivier R; Escobar P; Caicedo A; Brigitte M; Lazennec G
Endocr Relat Cancer; 2011 Jun; 18(3):311-21. PubMed ID: 21389059
[TBL] [Abstract][Full Text] [Related]
20. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system.
Hill SM; Spriggs LL; Simon MA; Muraoka H; Blask DE
Cancer Lett; 1992 Jul; 64(3):249-56. PubMed ID: 1638517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
